Author

Martin Novak

University Hospital Hradec Králové

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Anezka PelikanovaiD· 1 shared Anna MisiachnaiD· 1 shared Emily LangoreiD· 1 shared Jakub NetolickýiD· 1 shared Jan KonecnyiD· 1 shared Jan KorábečnýiD· 1 shared Jana Žďárová KarasováiD· 1 shared Jaroslav PejchaliD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anezka PelikanovaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition

Anna Misiachna, Jan Konecny, Marharyta Kolcheva, Marek Ladislav, Lukáš Prchal, Jakub Netolický, Štěpán Kortus, Petra Zahumenska, Emily Langore, Martin Novak, Katarína Hemelíková, Zuzana Heřmanová, Michaela Hrochová, Anezka Pelikanova, Jitka Odvarkova, , Martin Hořák

This paper develops a novel NMDA receptor open-channel blocker, K2060, showing improved efficacy and reversibility compared to existing drugs like memantine and dizocilpine.

Biomedicine & Pharmacotherapy · Jul 24, 2024Peer-reviewedNeuroscience